DZ2576A1 - Compositions parentérales d'alatrofloxacine. - Google Patents

Compositions parentérales d'alatrofloxacine.

Info

Publication number
DZ2576A1
DZ2576A1 DZ980186A DZ980186A DZ2576A1 DZ 2576 A1 DZ2576 A1 DZ 2576A1 DZ 980186 A DZ980186 A DZ 980186A DZ 980186 A DZ980186 A DZ 980186A DZ 2576 A1 DZ2576 A1 DZ 2576A1
Authority
DZ
Algeria
Prior art keywords
alatrofloxacin
parenteral compositions
parenteral
compositions
Prior art date
Application number
DZ980186A
Other languages
English (en)
French (fr)
Inventor
Robert Mark Guinn
John Francis Lambert
Subramanian Sam Guhan
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2576A1 publication Critical patent/DZ2576A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
DZ980186A 1997-08-01 1998-07-29 Compositions parentérales d'alatrofloxacine. DZ2576A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
DZ2576A1 true DZ2576A1 (fr) 2003-02-22

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980186A DZ2576A1 (fr) 1997-08-01 1998-07-29 Compositions parentérales d'alatrofloxacine.

Country Status (40)

Country Link
US (1) US6194429B1 (pt)
EP (1) EP1000086B1 (pt)
JP (1) JP3463928B2 (pt)
KR (1) KR20010022495A (pt)
CN (1) CN1265671A (pt)
AP (1) AP1031A (pt)
AR (1) AR015417A1 (pt)
AT (1) ATE259827T1 (pt)
AU (1) AU734863B2 (pt)
BG (1) BG104105A (pt)
BR (1) BR9811580A (pt)
CA (1) CA2296466C (pt)
CO (1) CO4970688A1 (pt)
DE (1) DE69821767T2 (pt)
DK (1) DK1000086T3 (pt)
DZ (1) DZ2576A1 (pt)
EA (1) EA002120B1 (pt)
ES (1) ES2214716T3 (pt)
GT (1) GT199800112A (pt)
HN (1) HN1998000106A (pt)
HR (1) HRP980417B1 (pt)
HU (1) HUP0004793A3 (pt)
ID (1) ID24374A (pt)
IL (1) IL134156A0 (pt)
IS (1) IS5339A (pt)
MA (1) MA24626A1 (pt)
NO (1) NO20000485L (pt)
NZ (1) NZ502249A (pt)
OA (1) OA11281A (pt)
PA (1) PA8456701A1 (pt)
PE (1) PE103799A1 (pt)
PL (1) PL338477A1 (pt)
PT (1) PT1000086E (pt)
SK (1) SK1012000A3 (pt)
TN (1) TNSN98146A1 (pt)
TW (1) TW538043B (pt)
UY (1) UY25113A1 (pt)
WO (1) WO1999006430A1 (pt)
YU (1) YU2500A (pt)
ZA (1) ZA986874B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148820A0 (en) * 1999-10-08 2002-09-12 Smithkline Beecham Corp Fab i inhibitors
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
WO2003088897A2 (en) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
JP5087406B2 (ja) 2004-06-04 2012-12-05 アフィニウム ファーマシューティカルズ, インク. 治療薬ならびにその製造方法および使用方法
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ, インク. Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
DK2861608T3 (da) 2012-06-19 2019-06-24 Debiopharm Int Sa Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid
KR20160144499A (ko) * 2014-04-25 2016-12-16 노렉스, 인크. 신경활성 펩타이드의 안정한 조성물
CN108778286A (zh) 2016-02-26 2018-11-09 德彪药业国际股份公司 用于治疗糖尿病足感染的药物
CN111971292A (zh) 2018-02-02 2020-11-20 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CN1141634A (zh) 1994-01-18 1997-01-29 辉瑞大药厂 萘啶酮羧酸盐的制备方法和中间体
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
ATE221544T1 (de) 1995-06-15 2002-08-15 Pfizer Verfahren zur herstellung von derivaten der ein peptid enthaltenden azabizylo-naphtyridin- carbonsäure
DE69617027T2 (de) 1995-08-29 2002-03-21 Pfizer Inc., New York Polymorphs von prodrug 6-n(l-ala-l-ala)-trovafloxacin
CA2229786C (en) 1995-08-29 2002-02-19 David Bruning Joseph Zwitterionic forms of trovafloxacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
CO4970688A1 (es) 2000-11-07
WO1999006430A1 (en) 1999-02-11
HN1998000106A (es) 1999-01-08
DE69821767D1 (de) 2004-03-25
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
JP2001512133A (ja) 2001-08-21
MA24626A1 (fr) 1999-04-01
DK1000086T3 (da) 2004-05-17
EP1000086B1 (en) 2004-02-18
CA2296466A1 (en) 1999-02-11
HRP980417A2 (en) 1999-08-31
BR9811580A (pt) 2000-08-22
CN1265671A (zh) 2000-09-06
AR015417A1 (es) 2001-05-02
HUP0004793A3 (en) 2001-10-29
ATE259827T1 (de) 2004-03-15
YU2500A (sh) 2002-09-19
BG104105A (bg) 2000-08-31
KR20010022495A (ko) 2001-03-15
JP3463928B2 (ja) 2003-11-05
TNSN98146A1 (fr) 2005-03-15
HUP0004793A2 (hu) 2001-04-28
NO20000485L (no) 2000-03-27
HRP980417B1 (en) 2002-10-31
AP9801310A0 (en) 1998-09-30
AU734863B2 (en) 2001-06-21
ES2214716T3 (es) 2004-09-16
SK1012000A3 (en) 2000-09-12
DE69821767T2 (de) 2005-01-13
ID24374A (id) 2000-07-13
AU8236898A (en) 1999-02-22
IL134156A0 (en) 2001-04-30
GT199800112A (es) 2000-01-15
PE103799A1 (es) 1999-10-25
AP1031A (en) 2001-12-21
EA002120B1 (ru) 2001-12-24
ZA986874B (en) 2000-01-31
EA200000086A1 (ru) 2000-08-28
NO20000485D0 (no) 2000-01-31
PA8456701A1 (es) 2000-05-24
CA2296466C (en) 2003-04-15
OA11281A (en) 2002-11-19
IS5339A (is) 2000-01-14
NZ502249A (en) 2001-11-30
US6194429B1 (en) 2001-02-27
PT1000086E (pt) 2004-05-31
EP1000086A1 (en) 2000-05-17
UY25113A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
DE69616804D1 (de) Wasserdispergierbare copolyester-ether zusammensetzungen
FI974241A0 (fi) BPM-15 -koostumukset
NO996108D0 (no) 9-oksinerytromycinderivater
DZ2576A1 (fr) Compositions parentérales d'alatrofloxacine.
NO981568D0 (no) Randtennings-tennsatssammensetninger
NO980290D0 (no) 2(4-substituert)benzylamino-2-metylpropanamidderivater
DE69617029D1 (de) Organoton-zusammensetzungen
ITMI941407A0 (it) Composizioni cementizie mdf con migliorata tenacita'
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
PL340372A1 (en) Novel 3,6x-hemiketals of 9a-azalydes class
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
DE69603228D1 (de) Aluminoxanate-Zusammensetzungen
BR9709521A (pt) "3-Cianoaril-pirazóis"
EE9800168A (et) Tahked kompositsioonid
IT1272346B (it) "accessorio di raccordo".
MA26481A1 (fr) Derives d'arylsecocholadiene
FR2710673B1 (fr) Composition d'enduit de parement.
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
FR2735986B3 (fr) Prolongateur d'haltere
FR2724962B3 (fr) Tuile d'avant-toit sous-faitiere.
KR970702873A (ko) 17β-시아노-3-에톡시-17α-하이드록시-6-메틸안드로스타-3,5,9-트리엔의 합성 방법(SYNTHESIS OF 17β-CYANO-3-ETHOXY-17α-HYDROXY-6-METHYLANDROSTA-3,5,9-TRIENE)
UA1629S (uk) Набір фестонів "веснянка-5"
UA2139S (uk) Обкладинка телефонного довідника "жовті сторінки"
UA1914S (uk) Крекер "фірмовий"
ITCS970006V0 (it) "1 m"